Viridian Therapeutics, Inc. (VRDN)
28.35
+1.16
(+4.27%)
USD |
NASDAQ |
Mar 25, 16:00
28.37
+0.02
(+0.07%)
After-Hours: 20:00
Viridian Therapeutics EPS Diluted (Quarterly) : -1.080 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1022 |
| Plus Therapeutics, Inc. | -0.0412 |
| Nutriband, Inc. | -0.3212 |
| Immunovant, Inc. | -0.6095 |
| Definium Therapeutics, Inc. | -0.5106 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -101.98M |
| Revenue (Quarterly) | 0.132M |
| Total Expenses (Quarterly) | 102.11M |
| Enterprise Value | 2.206B |
| Gross Profit Margin (Quarterly) | -142.4% |
| Profit Margin (Quarterly) | -77.26K% |
| Earnings Yield | -13.43% |
| Normalized Earnings Yield | -13.41 |